Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study

MLA

Fava, Maurizio, et al. “Lithium and Tricyclic Augmentation of Fluoxetine Treatment for Resistant Major Depression: A Double-Blind, Controlled Study.” American Journal of Psychiatry, vol. 151, no. 9, Sept. 1994, p. 1372. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.16084831&authtype=sso&custid=ns315887.

APA

Fava, M., Rosenbaum, J. F., McGrath, P. J., Stewart, J. W., Amsterdam, J. D., & Quitkin, F. M. (1994, September 1). Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study. American Journal of Psychiatry, 151(9), 1372.

Chicago

Fava, Maurizio, Jerrold F. Rosenbaum, Patrick J. McGrath, Jonathan W. Stewart, Jay D. Amsterdam, and Frederic M. Quitkin. 1994. “Lithium and Tricyclic Augmentation of Fluoxetine Treatment for Resistant Major Depression: A Double-Blind, Controlled Study.” American Journal of Psychiatry, September 1. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.16084831&authtype=sso&custid=ns315887.